The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades

被引:39
|
作者
Romero-Pinel, Lucia [1 ]
Bau, Laura [1 ]
Matas, Elisabet [1 ]
Leon, Isabel [1 ]
Munoz-Vendrell, Albert [1 ]
Arroyo, Pablo [1 ]
Masuet-Aumatell, Cristina [2 ]
Martinez-Yelamos, Antonio [1 ,3 ]
Martinez-Yelamos, Sergio [1 ,3 ]
机构
[1] Hosp Univ Bellvitge IDIBELL, Multiple Sclerosis Unit, Dept Neurol, Barcelona, Spain
[2] Hosp Univ Bellvitge IDIBELL, Dept Epidemiol & Prevent Med, Barcelona, Spain
[3] Univ Barcelona UB, Fac Med & Ciencies Salut, Dept Ciencies Clin, Barcelona, Spain
关键词
Age at onset; Disease course; Epidemiology; Multiple sclerosis; Relapsing-remitting; EPSTEIN-BARR-VIRUS; DIAGNOSTIC-CRITERIA; VITAMIN-D; PREVALENCE; RISK; ANTICIPATION; INFECTION; SMOKING; OBESITY;
D O I
10.1016/j.msard.2022.104103
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) most commonly experience their first symptoms between 20 and 40 years of age. The objective of this study was to investigate how the age at which the first symptoms of RRMS occur has changed over the past decades. Methods: Patients who were followed up in our unit after an initial diagnosis of RRMS using the Poser or McDonald criteria and who experienced their first symptoms between January 1970 and December 2019 were included in the study. The cohort was divided into five groups according to the decade in which the first symptoms appeared. The age at disease onset was compared across decades. Changes in age were also deter-mined after excluding patients with early-onset disease (< 18 years of age) and those with late-onset disease (> 50 years of age) to avoid bias. Results: The cohort included 1,622 patients with RRMS, 67.6% of whom were women. Among them, 5.9% and 4% had early-onset and late-onset disease, respectively. The mean age +/- standard deviation at onset was 31.11 +/- 9.82 years, with no differences between men and women. The mean ages at onset were 23.79 +/- 10.19 years between 1970 and 1979, 27.86 +/- 9.22 years between 1980 and 1989, 30.07 +/- 9.32 years between 1990 and 1999, 32.12 +/- 9.47 between 2000 and 2009, and 34.28 +/- 9.83 years between 2010 and 2019. The ages at disease onset were progressively higher in the later decades; this trend was statistically significant (p < 0.001), with a Pearson linear correlation coefficient R of 0.264 and R2 of 0.070 (p < 0.001). The results were similar when analysing men and women separately. We conducted an analysis of 1,460 patients (mean age at onset: 31.10 +/- 7.99 years), after excluding patients with early-onset and late-onset disease. In this specific subgroup, the mean ages at disease onset were 28.38 +/- 8.17 years between 1970 and 1979, 29.22 +/- 7.51 years between 1980 and 1989, 30.06 +/- 8.02 years between 1990 and 1999, 31.46 +/- 7.77 years between 2000 and 2009, and 33.37 +/- 7.97 years between 2010 and 2019. The trend was also statistically significant (p < 0.001), with a Pearson linear correlation coefficient R of 0.193 and R2 of 0.037 (p < 0.001). Conclusion: Our data showed that the age at RRMS onset has increased over the past decades.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Clinical features of 314 patients with relapsing-remitting multiple sclerosis
    Nogales-Gaete, Jorge
    Aracena, Rodrigo
    Cepeda-Zumaeta, Sergio
    Eloiza, Claudio
    Agurto, Paula
    Diaz, Vannia
    Labbe, Silvia
    Martinez, Sefora
    Flores, Jazmin
    Araya, Casandra
    REVISTA MEDICA DE CHILE, 2014, 142 (05) : 559 - 566
  • [42] Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?
    Clarence Liu
    E. Diane Playford
    Alan J. Thompson
    Journal of Neurology, 2003, 250 : 1214 - 1218
  • [43] Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations
    Gallo, P.
    Van Wijmeersch, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 14 - 21
  • [44] Subtypes of relapsing-remitting multiple sclerosis identified by network analysis
    Howlett-Prieto, Quentin
    Oommen, Chelsea
    Carrithers, Michael D.
    Wunsch II, Donald C.
    Hier, Daniel B.
    FRONTIERS IN DIGITAL HEALTH, 2023, 4
  • [45] Cognitive function and oral health in relapsing-remitting multiple sclerosis
    Manchery, Nithin
    Henry, Julie D.
    Swayne, Andrew
    Beer, Reuben
    Blum, Stefan
    Nangle, Matthew R.
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (03) : 2899 - 2907
  • [46] Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis
    Esposito, Federica
    Radaelli, Marta
    Martinelli, Vittorio
    Sormani, Maria Pia
    Boneschi, Filippo Martinelli
    Moiola, Lucia
    Rocca, Maria Assunta
    Rodegher, Mariaemma
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1490 - 1499
  • [47] Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis
    Bartnik, Pawel
    Wielgos, Aleksandra
    Kacperczyk, Joanna
    Pisarz, Katarzyna
    Szymusik, Iwona
    Podlecka-Pietowska, Aleksandra
    Zakrzewska-Pniewska, Beata
    Wielgos, Miroslaw
    BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [48] Clinical features of relapsing-remitting multiple sclerosis prognostic factors
    Fernández-Fernández, O
    REVISTA DE NEUROLOGIA, 2002, 35 (11) : 1067 - 1073
  • [49] Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis
    Bansback, Nick
    Chiu, Judy A.
    Metcalfe, Rebecca
    Lapointe, Emmanuelle
    Schabas, Alice
    Lenzen, Marilyn
    Traboulsee, Anthony
    Lynd, Larry D.
    Carruthers, Robert
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (03)
  • [50] Cognitive impairment and depression in patients with relapsing-remitting multiple sclerosis depending on age and neuroimaging findings
    Kopchak, Oksana O.
    Odintsova, Tetiana A.
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01)